 |
CME SLIDES FORUM
Archive 2006
 |
Impact of immunosuppressive agents on cardiovascular risk profile
|
 |
The role of lipids and new onset diabetes mellitus
|
Prof F.P. Schena |
Prof
J.M. Campistol Fac. of Medicine, Renal Transplantation Unit University Hospital Barcelona, Spain |
||
 |
The contribution of CMV infection to cardiovascular complications after renal transplantation |
||
| Prof
C. Legendre Necker Hospital Paris University V Paris, France |
|||
 |
Novel roles of the renal lymphatic system in health and disease
|
 |
A genetic look at nephrolithiasis: therapeutic implications
|
Dr D. Kerjaschki |
Dr G. Gambaro Nephrology Division, Ospedale Maggiore University of Verona Verona, Italy |
||
 |
Therapeutic approaches to hyperphosphatemia in chronic renal failure |
||
| Prof T.B. Drueke Inserm U507 and Service de Nephrologie Hôpital Necker Paris, France |
|||
 |
Probing oxidant injury in the renal biopsy
|
 |
|
Dr M.P. Rastaldi |
Dr W.L. Gross Dept. of Rheumatology – University of Schleswig-Holstein, Campus Lübeck Hospital of Internal Medicine and Clinical Immunology, Rheumaklinik Bad Bramstedt Lübeck, Germany |
||
 |
Optimisation of maintenance treatments in ANCA-associated vasculitis |
||
| Dr L. Guillevin Hôpital Cochin University Paris - René Descartes Paris, France |
|||
 |
Cellular oxygen sensing in health and disease: from erythropoietin to oxygen |
 |
|
Prof P.J. Ratcliffe |
Dr C. Chatziantoniou Inserm U.702 Hopital Tenon Paris, France |
||
 |
|||
| Prof G. Remuzzi Mario Negri Institute for Pharmacological Researches Negri Bergamo Laboratories Bergamo, Italy |
|||
 |
Mechanisms of vascular smooth muscle cell calcification |  |
Genetic models and diseases of vascular calcification |
Dr C.M. Shanahan |
Dr M. Ketteler Department of Nephrology University Hospital Aachen Aachen, Germany |
||
 |
The bone and vascular connection | ||
| Prof J. Cannata-Andia Servicio de Metabolismo Oseo y Mineral Instituto “Reina Sofía” de Investigación, Hospital Central de Asturias Oviedo, Spain |
|||
 |
Novel immunosuppressive regimens - an overview
|
 |
Role of matrix metalloproteases in disease progression and repair: the two faces of the coin
|
Prof H. Ekberg |
Prof P. Ronco INSERM Unit 702, University Pierre and Marie Curie Tenon Hospital Paris, France |
||
 |
|
 |
|
Dr M. Moeller |
Dr L. Gesualdo S.C. di Nefrologia e Dialisi Azienda Ospedaliero-Universitaria 'OO.RR.' Foggia, Italy |
||
|
The intrarenal lymphatic system contributes to progressive damage |
|
|
| Dr D. Kerjaschki Department of Pathology Medical University of Vienna Vienna, Austria |
|||
 |
Coordinated regulation of renal calcium transport by vitamin D and dietary calcium |
 |
|
Prof
R. Bindels |
Dr
Y. Imanishi Department of Metabolism, Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine Osaka, Japan |
||
|
Coordinated regulation of renal calcium transport by vitamin D and dietary calcium |
|
|
Prof
R. Bindels |
Dr
Y. Imanishi Department of Metabolism, Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine Osaka, Japan |
||
 |
 |
||
Prof T. Akpolat |
Dr D. Toncheva-Miteva Department of Medical Genetics Medical University of Sofia Sofia, Bulgaria |
||
 |
Available methods of GFR determination: a critical assessment |
 |
|
Prof P.E. De Jong |
Prof J. Radermacher Department of Nephrology Klinikum Minden Minden, Germany |
||
 |
Diagnostic problems in diabetic nephropathy: histological findings and non-immunoreactive albumin |
 |
Insulin resistance and its role on initiation and progression of diabetic nephropathy |
Prof
P. Fioretto |
Prof
M. Laville Service de Nephrology - Universitè Claude Bernard Hopital E. Herriot Lyon, France |
||
 |
Diabetic nephropathy: epidemiology and prevention | ||
| Prof
M. Ravid Sakler Faculty of Medicine University of Tel Aviv Tel Aviv, Italy |
|||
|
|
 |
|
Prof J.M. Campistol |
Prof J.P. Grünfeld Université Paris-Descartes Hôpital Necker Paris, France |
||
 |
|
 |
Treatment of idiopathic nephrotic syndrome with immunophillin modulation |
Prof
R. Coppo |
Prof A. Meyrier Nephrology Service INSERM U430 University Hospitals Broussais & HEGP Paris, France |
||
 |
|||
| Prof
M. Daha Dept of Nephrology Leiden University Medical Center Leiden, The Netherlands |
|||
 |
|
||
Prof
D. Fliser |
|||
 |
Biochemical indicators of endothelial dysfunction in CKD and hypertension |
 |
|
Dr F. Mallamaci |
Prof G. Wolf Department of Medicine University of Jena Jena, Germany |
||
 |
 |
Treatment of thrombotic microangiopathy
|
|
Prof G. Remuzzi |
Prof. C. Loirat Service de Nephrologie Pediatrique Hopital Robert Debre Paris, France |
||
 |
 |
||
| Dr. P. Ruggenenti Renal Research Department Mario Negri Institute Bergamo, Italy |
Dr. S. Goral Division of Renal, Electrolytes and Hypertension University of Pennsylvania School of Medicine Philadelphia, PA, USA |
||
 |
Tubular sodium handling and hypertension.
|
 |
Renovascular hypertension and atherosclerotic nephropathy. How to diagnose and treat
|
Prof M. Burnier |
Dr
J. Scoble Renal Unit Guy’s Hospital London, United Kingdom |
||
 |
 |
||
Dr E.J. Will |
Prof N. Levin Renal Research Institute Albert Einstein College of Medicine New York, NY, USA |
||
 |
 |
||
| Prof G. Eknoyan Renal Section, Department of Medicine Baylor College of Medicine Houston, TX, USA |
Prof
R. Vanholder Nephrology Section, Department of Internal |
||
 |
General overview: bone remodelling and chronic renal failure |
 |
Low bone turnover: should we stimulate bone turnover in dialysis patients
|
Prof G. Coen |
Prof T.B. Drueke Inserm U507 and Service de Nephrologie Hôpital Necker Paris, France |
||
 |
 |
Effect of biofeedback systems for monitoring haemodialysis treatments |
|
Prof N. Lameire Chief Renal Division University of Ghent Ghent, Belgium |
Prof T. Petitclerc Department of Nephrology Pitié-Salpétrière Hospital Paris, France |
||
 |
Dialysis |  |
Glomerular, tubular and interstitial diseases: advances in basic and clinical science |
| Dr F. Locatelli Dipartimento Nefro-Urologico Ospedale "A. Manzoni" Lecco, Italy |
Prof. D. Schlöndorff Direktor Medizinische Poliklinik - Innenstadt Klinikum der Universität München Munich, Germany |
||
 |
The association between CKD and cardiovascular disease: cause or consequence? |  |
Endothelial dysfunction and early renal dysfunction |
| Dr P. Parfrey Memorial University of Newfoundland St. John's Newfoundland, Canada |
Prof C. Zoccali Unità di Nefrologia, Dialisi, Trapianto e Ipertensione OO.RR and CNR Istituto di Biomedicina Laboratorio di Epidemiologia Clinica e Fisiopatologia delle malattie Renali e dell'Ipertensione Reggio Calabria, Italy |
||
 |
Differential indication for ace-inhibitors, at1-blockers and their combination |
|
Aldosterone and kidney disease: what are the links?
|
|
Prof P.-Y. Martin Division of Nephrology Department of Medicine Geneva University Hospital Geneva, Switzerland |
||
 |
Global epidemiology and public health: the years of epidemiologic transition |
 |
|
|
Dr R.N. Foley Nephrology Analytical Services, Chronic Disease Research Group Minneapolis Medical Research Foundation and University of Minnesota Minneapolis, MN, USA |
||
|
|||
 |
 |
Vascular access practice patterns and outcomes across DOPPS countries |
|
|
|
||